What is ProScience Research Group?
ProScience Research Group operates as a specialized clinical research organization dedicated to the advancement of therapeutic solutions for complex mental health conditions. By leveraging a robust team of Principal Investigators and Clinical Research Coordinators, the firm facilitates high-quality data collection across a diverse spectrum of neurological and psychiatric disorders, including ADHD, Alzheimer's, and schizophrenia. Their market position is defined by a dual commitment to patient safety and the acceleration of medical innovation, positioning them as a critical partner for pharmaceutical developers seeking to improve patient outcomes through evidence-based research methodologies.
How much funding has ProScience Research Group raised?
ProScience Research Group has raised a total of $101K across 1 funding round:
Debt
$101K
Debt (2021): $101K with participation from PPP
Key Investors in ProScience Research Group
PPP
Public-Private Partnership
What's next for ProScience Research Group?
With this late-stage capital, ProScience Research Group is well-positioned to scale its clinical trial infrastructure and broaden its therapeutic research portfolio. The strategic deployment of these funds will likely focus on enhancing operational efficiencies and expanding the reach of their mental health studies, which are essential for the development of next-generation therapies. As the company matures, the focus will shift toward optimizing data integrity protocols and strengthening partnerships with global health stakeholders to ensure that their research findings translate effectively into improved clinical standards and patient quality of life.
See full ProScience Research Group company page
